Ziopharm Oncology (ZIOP) Prices 27.83M Share Common Offering at $3.25/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall St set for higher open as AI stocks rise, oil slides
- Oil prices slide to 11-day low on hopes of US-Iran diplomacy, Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- Wall St set for higher open as AI stocks rise, oil slides
- Streamflation drives 39% of Americans to cancel streaming in 6 months
Ziopharm Oncology (ZIOP) Prices 27.826M Share Common Offering at $3.25/Sh
February 7, 2020 5:59 AM ESTZiopharm Oncology, Inc. (Nasdaq: ZIOP) today announced the pricing of an underwritten public offering of 27,826,086 shares of its common stock at a public offering price of $3.25 per share. Ziopharm has granted the underwriters a 30-day option to purchase up to an additional 4,173,912... More
Ziopharm Oncology (ZIOP) Announces Proposed Common Share Offering
February 7, 2020 5:56 AM ESTZiopharm Oncology, Inc. (NASDAQ: ZIOP) today announced that it intends to offer and sell shares of its common stock in an underwritten registered public offering. All of the shares in the offering are to be sold by Ziopharm. Ziopharm also intends to grant the... More
After-Hours Stock Movers 02/04: (USNA) (MKSI) (PYPL) Higher; (PLT) (KN) (ZIOP) Lower (more...)
February 4, 2020 6:06 PM ESTAfter-Hours Stock Movers
Plantronics (NYSE: PLT) 30% LOWER; reported Q3 EPS of $0.30, $0.16 better than the analyst estimate of $0.14. Revenue for the quarter came in at $392 million versus the consensus estimate of $400.51 million. Plantronics sees Q4 2020 EPS of ($0.36)-$0.19, versus the consensus of $0.51. Plantronics sees Q4 2020 revenue of $354-394 million, versus the consensus of $441 million.
USANA Health Sciences (NYSE: USNA) 21.2% HIGHER; reported Q4 EPS of $1.41, $0.43 better than the analyst estimate of $0.98. Revenue for the quarter came in at $271.3 million versus the... More
Ziopharm Oncology (ZIOP) to Offer Common Stock
February 4, 2020 4:02 PM ESTZiopharm Oncology, Inc. (Nasdaq: ZIOP) today announced that it intends to offer and sell shares of its common stock in an underwritten registered public offering. All of the shares in the offering are to be sold by Ziopharm. Ziopharm also intends to grant the... More

